1
|
Kim JY, Kim JY, Kim JH, Jung H, Lee WT, Lee JE. Restorative Mechanism of Neural Progenitor Cells Overexpressing Arginine Decarboxylase Genes Following Ischemic Injury. Exp Neurobiol 2019; 28:85-103. [PMID: 30853827 PMCID: PMC6401554 DOI: 10.5607/en.2019.28.1.85] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2018] [Revised: 12/17/2018] [Accepted: 12/20/2018] [Indexed: 12/13/2022] Open
Abstract
Cell replacement therapy using neural progenitor cells (NPCs) following ischemic stroke is a promising potential therapeutic strategy, but lacks efficacy for human central nervous system (CNS) therapeutics. In a previous in vitro study, we reported that the overexpression of human arginine decarboxylase (ADC) genes by a retroviral plasmid vector promoted the neuronal differentiation of mouse NPCs. In the present study, we focused on the cellular mechanism underlying cell proliferation and differentiation following ischemic injury, and the therapeutic feasibility of NPCs overexpressing ADC genes (ADC-NPCs) following ischemic stroke. To mimic cerebral ischemia in vitro , we subjected the NPCs to oxygen-glucose deprivation (OGD). The overexpressing ADC-NPCs were differentiated by neural lineage, which was related to excessive intracellular calcium-mediated cell cycle arrest and phosphorylation in the ERK1/2, CREB, and STAT1 signaling cascade following ischemic injury. Moreover, the ADC-NPCs were able to resist mitochondrial membrane potential collapse in the increasingly excessive intracellular calcium environment. Subsequently, transplanted ADC-NPCs suppressed infarct volume, and promoted neural differentiation, synapse formation, and motor behavior performance in an in vivo tMCAO rat model. The results suggest that ADC-NPCs are potentially useful for cell replacement therapy following ischemic stroke.
Collapse
Affiliation(s)
- Jae Young Kim
- Department of Anatomy, Yonsei University College of Medicine, Seoul 03722, Korea
| | - Jong Youl Kim
- Department of Anatomy, Yonsei University College of Medicine, Seoul 03722, Korea
| | - Jae Hwan Kim
- Department of Anatomy, Yonsei University College of Medicine, Seoul 03722, Korea
- Center for Neuroscience Imaging Research (CNIR), Institute for Basic Science, Sungkyunkwan University, Suwon 16419, Korea
| | - Hosung Jung
- Department of Anatomy, Yonsei University College of Medicine, Seoul 03722, Korea
- BK21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, Korea
| | - Won Taek Lee
- Department of Anatomy, Yonsei University College of Medicine, Seoul 03722, Korea
| | - Jong Eun Lee
- Department of Anatomy, Yonsei University College of Medicine, Seoul 03722, Korea
- BK21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, Korea
- Brain Research Institute, Yonsei University College of Medicine, Seoul 03722, Korea
| |
Collapse
|
2
|
Wu SW, Fowler DK, Shaffer FJ, Lindberg JEM, Peters JH. Ethyl Vanillin Activates TRPA1. J Pharmacol Exp Ther 2017; 362:368-377. [PMID: 28620120 DOI: 10.1124/jpet.116.239384] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2016] [Accepted: 05/19/2017] [Indexed: 01/11/2023] Open
Abstract
The nonselective cation channel transient receptor potential ankryn subtype family 1 (TRPA1) is expressed in neurons of dorsal root ganglia and trigeminal ganglia and also in vagal afferent neurons that innervate the lungs and gastrointestinal tract. Many TRPA1 agonists are reactive electrophilic compounds that form covalent adducts with TRPA1. Allyl isothiocyanate (AITC), the common agonist used to identify TRPA1, contains an electrophilic group that covalently binds with cysteine residues of TRPA1 and confers a structural change on the channel. There is scientific motivation to identify additional compounds that can activate TRPA1 with different mechanisms of channel gating. We provide evidence that ethyl vanillin (EVA) is a TRPA1 agonist. Using fluorescent calcium imaging and whole-cell patch-clamp electrophysiology on dissociated rat vagal afferent neurons and TRPA1-transfected COS-7 cells, we discovered that EVA activates cells also activated by AITC. Both agonists display similar current profiles and conductances. Pretreatment with A967079, a selective TRPA1 antagonist, blocks the EVA response as well as the AITC response. Furthermore, EVA does not activate vagal afferent neurons from TRPA1 knockout mice, showing selectivity for TRPA1 in this tissue. Interestingly, EVA appears to be pharmacologically different from AITC as a TRPA1 agonist. When AITC is applied before EVA, the EVA response is occluded. However, they both require intracellular oxidation to activate TRPA1. These findings suggest that EVA activates TRPA1 but via a distinct mechanism that may provide greater ease for study in native systems compared with AITC and may shed light on differential modes of TRPA1 gating by ligand types.
Collapse
Affiliation(s)
- Shaw-Wen Wu
- Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington (D.K.F., F.J.S., J.E.M.L., J.H.P.); and Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida (S.-w.W.)
| | - Daniel K Fowler
- Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington (D.K.F., F.J.S., J.E.M.L., J.H.P.); and Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida (S.-w.W.)
| | - Forrest J Shaffer
- Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington (D.K.F., F.J.S., J.E.M.L., J.H.P.); and Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida (S.-w.W.)
| | - Jonathon E M Lindberg
- Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington (D.K.F., F.J.S., J.E.M.L., J.H.P.); and Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida (S.-w.W.)
| | - James H Peters
- Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington (D.K.F., F.J.S., J.E.M.L., J.H.P.); and Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida (S.-w.W.)
| |
Collapse
|
3
|
Abstract
INTRODUCTIONDuring the past decades, many different fluorescent indicators have been developed for measuring intracellular ion concentrations. Of particular interest are fluorescent calcium indicators because of the fundamental role of Ca2+in various cellular processes such as contraction, secretion, and gene activation. For a quantitative understanding of the physiological roles of Ca2+, fluorescence signals measured with calcium indicators have to be converted to intracellular free calcium concentration ([Ca2+]i). Similarly, changes in [Ca2+]iand the underlying calcium fluxes need to be inferred from the corresponding fluorescence changes. This article describes the theoretical background and the various principal methods for the calibration of calcium imaging data.
Collapse
|